6993 — Deck
Blue Moon Group Holdings · 6993 · HKEX
China's #1 liquid laundry detergent, a single-brand FMCG franchise earning roughly 60% gross margin on Blue Moon detergent and home-care products — 88% fabric care, 59% sold online, almost entirely inside China.
HK$2.96
Price
HK$17.3B
Market cap
HK$8.4B
Revenue (TTM)
59.7%
Gross margin
Listed December 2020 at HK$15.32, peaked at HK$19.16 in January 2021, bottomed at HK$1.68 in January 2024 — sits at HK$2.96 today, roughly 81% below the IPO print.
2 · The tension
A 60%-gross-margin brand lost the ability to reach its customers cheaply.
- Gross margin — intact. Held in a 58–64% band for six straight years through revenue stress and the swing from +25% to −4% operating margin. The brand still commands a premium price. The moat is the product, not distribution.
- Selling expense — doubled. S&M rose from 28.8% of revenue in FY2020 to 59.0% in FY2024 before easing to 53.1% in FY2025. The cost of acquiring a Chinese detergent buyer on Tmall, JD and Douyin exploded while category volumes stayed flat.
- The arithmetic. S&M consumed 89% of FY2025 gross profit. If Blue Moon spent 38% of revenue on marketing — Colgate's level on a similar gross margin — FY2025 prints around HK$1.3B of operating profit instead of HK$355M of loss.
Either channel cost normalises and the earnings power snaps back, or this is a structurally broken business. The entire thesis fits on one line.
3 · Money picture
Peer-leading gross margin, worst-in-class operating margin — and a deposit pile funding the payout.
59.7%
Gross margin
peer-leading vs PG 51.2%
−4.2%
Operating margin
2nd loss year, narrowing
HK$3.7B
Net cash
zero debt, 21% of mkt cap
HK$1.6B
FY25 cash burn
~2.3 years runway
Revenue has run in a HK$7.0–8.6B band since the 2020 IPO, so scale is not the problem. Gross margin held through the collapse; operating margin fell 25 points on distribution cost alone. Two-thirds of the HK$10.9B IPO deposit pile is gone; what remains has to cover the loss and a newly hiked dividend until S&M reverts.
4 · Capital return, second loss year
Management hiked the dividend 80% and authorised a 10% buyback — one day after a second annual loss.
- Buyback. On 2026-03-27 Blue Moon authorised repurchase of up to 586M shares — roughly 10% of issued capital — under the 2025 AGM mandate. The first listed-share buyback in the company's history, announced the day after FY2025 results printed an HK$329M net loss.
- Dividend. FY2025 dividend raised to HK$0.18 per share (+80% YoY), a 6.1% trailing yield. Declared against HK$328.9M of reported losses and HK$1.6B of cash consumption during the year.
- Where the cash is coming from. IPO deposits of HK$10.9B at year-end 2020 have fallen to HK$3.7B at year-end 2025. Two-thirds of the pile has been spent in five years. Capital return is now funded from the shrinking balance, not from earnings.
Chairman Pan Dong owns 76% of every buyback share and every dividend dollar. A capital return that concentrates founder economics is a more complicated signal than it looks.
5 · Who runs this
Husband-and-wife co-founders control 76% of the stock and the executive board.
- Family at the top. Chairman Pan Dong (60) and CEO Luo Qiuping (62) are spouses and co-founders who jointly control ~76% via Aquarius Investment Holdings. A third Luo sits on the executive bench. Independence is at the HKEX floor — three of eight directors.
- Float is shrinking. Public free float sits at 21.15%, below the 25% default minimum. In January 2026 the company adopted HKEX Rule 13.32B — the alternative 10% threshold — which legally accommodates further concentration rather than broadening ownership.
- Pay disclosure — thin. Per-director emoluments are not in the results announcement. External data flags Chief Supply Officer Luo Dong at HK$36.8M total pay, 4.6× CEO Luo Qiuping's HK$8.0M — an unusual spread for a Hong-Kong-listed staples name and consistent with further family concentration on the executive bench.
Economic alignment with minorities is maximal. Minority voice is minimal. The two don't cancel each other.
6 · For & against
Lean cautious — the FY2025 cut landed, but the 2024 'strategic investment' is already falsified.
- For. Gross margin held 58–64% through the entire earnings collapse — the brand is not the broken piece. #1 in Chinese fabric care for 16 years, priced like Colgate on the product, an order of magnitude below Colgate on operating cost.
- For. FY2025 S&M fell HK$581M, operating loss narrowed 56%, gross margin did not crack. The first credible evidence in years that discipline can return without damage to the franchise.
- Against. Same FY2025 print: revenue −1.7%. A brand that cannot grow without an HK$5B promotion spigot is de-scaling, not recovering. The FY2024 'strategic investment' poured on HK$3B more of selling expense and bought zero revenue growth.
- Against. Dividend hike and 10% buyback funded from a deposit pile that has fallen HK$10.9B → HK$3.7B in five years. Cash runway at FY25 burn: ~2.3 years. Operating cash does not cover the payout; the IPO war chest does.
The brand is genuine. The capital plan is not. One data point flips the view — S&M at or below 48% of revenue with flat-or-up sales at H1 FY2026.
Watchlist to re-rate: H1 FY2026 interim results in August 2026 — three numbers end the debate: S&M as percent of revenue, YoY revenue growth, gross margin. 618 Festival in June and Singles Day in November preview both the H1 and H2 reads.